InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Lin Charles Y. Director active across 1 company, notably Kronos Bio, Inc.. Aggregated, 1 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €12k. Activity tracked since 21 February 2024. The latest transaction was filed on 21 February 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration